Bluejay Diagnostics, Inc. (NASDAQ:BJDX – Free Report)’s stock is set to reverse split before the market opens on Thursday, June 20th. The 1-8 reverse split was announced on Thursday, June 20th. The number of shares owned by shareholders will be adjusted after the market closes on Thursday, June 20th.
Bluejay Diagnostics Stock Performance
Shares of BJDX stock opened at $0.41 on Tuesday. Bluejay Diagnostics has a fifty-two week low of $0.34 and a fifty-two week high of $13.98. The stock has a 50 day moving average price of $0.54 and a two-hundred day moving average price of $1.04. The company has a market capitalization of $1.09 million, a P/E ratio of -0.05 and a beta of 1.06.
Bluejay Diagnostics (NASDAQ:BJDX – Get Free Report) last posted its earnings results on Thursday, March 28th. The company reported ($1.78) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.68) by ($1.10).
Hedge Funds Weigh In On Bluejay Diagnostics
Bluejay Diagnostics Company Profile
Bluejay Diagnostics, Inc, a medical diagnostic company, develops rapid test for the monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components.
Further Reading
- Five stocks we like better than Bluejay Diagnostics
- 3 Healthcare Dividend Stocks to Buy
- Buffett Bails on BYD: What It Means for the Future of EV Stocks
- What is a Low P/E Ratio and What Does it Tell Investors?
- Domino’s vs. Papa John’s: Stock Showdown of Pizza Giants
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Williams-Sonoma Makes Stock More Accessible with a Stock Split
Receive News & Ratings for Bluejay Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bluejay Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.